Skip to main content
Clinical Trials/NCT03525106
NCT03525106
Completed
N/A

Feasibility of a Positive Psychology Intervention for Hematopoietic Cell Transplant Survivors to Improve Quality of Life

Fred Hutchinson Cancer Center1 site in 1 country29 target enrollmentMay 18, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hematopoietic Cell Transplantation Recipient
Sponsor
Fred Hutchinson Cancer Center
Enrollment
29
Locations
1
Primary Endpoint
Study enrollment rates
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This trial studies a positive psychology intervention designed to improve quality of life in stem cell transplant survivors and their caregivers. Positive psychology (PP) uses systematic exercises (e.g., gratitude letters, acts of kindness) to potentially boost levels of optimism, resilience, and life enjoyment. PP interventions are often enjoyable, easy to understand, and can be delivered via telephone. PP intervention may improve the quality of life of participants who have undergone a stem cell transplant or their caregivers.

Detailed Description

PRIMARY OBJECTIVES: I. Pilot a positive psychology intervention delivered to hematopoietic cell transplantation (HCT) survivors and interested caregivers over an 8 week period. II. Determine the proportion of patients who enroll and the immediate benefit to participants, as measured by pre- and post-exercise measures of happiness and optimism. III. Pilot outcome data collection mechanisms in preparation for a randomized clinical trial. OUTLINE: Participants and caregivers receive a positive psychology exercise manual, complete positive psychology exercises every week, and participate in phone sessions over 30 minutes every week for 8 weeks. After completion of study, participants are followed up at 6 months.

Registry
clinicaltrials.gov
Start Date
May 18, 2018
End Date
March 1, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • English as primary language
  • At least 1 year after HCT

Exclusion Criteria

  • Major psychiatric diagnosis that impairs cognitive functioning or is not controlled at the time of the approach.
  • Medical conditions precluding participation in the intervention or likely to lead to death within 6 months, as determined by the principal investigator (PI)

Outcomes

Primary Outcomes

Study enrollment rates

Time Frame: Up to 8 weeks

The analysis of the study will mainly be descriptive. The proportion of participants who consent to enroll in the study will be computed based on the number approached through each method. Reasons for non-participation will be summarized. A larger randomized trial will be considered feasible if the enrollment rate for patients approached in person or over the phone is \> 50% (excluding the active opt-out rate) and the overall completeness of follow-up data collection is \> 70%, excluding patients who have died or are hospitalized/ill at the assessment point. Since the number of caregivers who will participate is unknown, caregiver analyses will also be descriptive only.

Positive psychology intervention completion rates

Time Frame: Up to 8 weeks

Completeness of follow-up data collection

Time Frame: Up to 8 weeks

Completeness is defined by the proportion of instrument scores that can be calculated per given time point. The completeness of follow-up data collection will be calculated and reported as a proportion of successfully completed scales versus scales attempted to be collected or completed by patients.

Changes in happiness after each exercise

Time Frame: Baseline up to 8 weeks

Change in happiness for each exercise will be analyzed by change scores. A change of 2 points on a 0-10 scale, with 10 being happiest, is considered clinically meaningful.

Changes in optimism after each exercise

Time Frame: Baseline up to 8 weeks

Change in optimism for each exercise will be analyzed by change scores. A change of 2 points on a 0-10 scale, with 10 being most optimistic, is considered clinically meaningful.

Changes in mental health

Time Frame: Baseline up to 6 months after intervention ends

This will be assessed with the patient-reported outcomes measurement information system, PROMIS-10 (Global-Mental). Higher scores are better. T scores will be used to standardize scores so that 50 represents the US general population and 10 is the standard deviation.

Changes in physical health

Time Frame: Baseline up to 6 months after intervention ends

This will be assessed with the patient-reported outcomes measurement information system, PROMIS-10 (Global-Physical). Higher scores are better. T scores will be used to standardize scores so that 50 represents the US general population and 10 is the standard deviation.

Changes in fatigue

Time Frame: Baseline up to 6 months after intervention ends

This will be assessed with the patient-reported outcomes measurement information system, PROMIS-Fatigue. Lower scores are better. T scores will be used to standardize scores so that 50 represents the US general population and 10 is the standard deviation.

Changes in pain

Time Frame: Baseline up to 6 months after intervention ends

This will be assessed with the patient-reported outcomes measurement information system, PROMIS-Pain interference. Lower scores are better. T scores will be used to standardize scores so that 50 represents the US general population and 10 is the standard deviation.

Changes in resilience

Time Frame: Baseline up to 6 months after intervention ends

This will be assessed with the Connor Davidson resilience scale. Total scores range from 0-40 with higher scores reflecting great resilience.

Changes in anxiety and depression

Time Frame: Baseline up to 6 months after intervention ends

The Hospital Anxiety and Depression Scale will be used to capture depression and anxiety. Scores on the Anxiety and Depression subscales range from 0-21 with higher scores indicating more distress. Subscales will be reported separately.

Study Sites (1)

Loading locations...

Similar Trials